Lidosen (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing sodium influx that is essential for depolarization. By inhibiting nerve impulse initiation and propagation, it produces a reversible loss of sensation in the area where it is administered.

The dose of Lidosen is determined by the prescribing clinician based on the specific procedure, patient weight, and injection site. No fixed regimen is provided here; the prescriber tailors the amount to achieve adequate anesthesia while minimizing risk.

Safety data for lidocaine hydrochloride in pregnancy are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies any potential risk to the fetus. Use while breastfeeding is also not well studied, so caution is advised.

To order Lidosen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Compared with longer‑acting agents such as bupivacaine, lidocaine has a faster onset and a shorter duration of action, making it ideal for brief procedures. Its safety profile is well established, and it is less likely to cause prolonged motor block, though it may require repeat dosing for longer surgeries.

Lidosen should be stored at ambient temperature below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct light, and ensure the container is tightly sealed to maintain sterility until use.

Lidosen is supplied as a sterile injectable solution for intramuscular or subcutaneous administration. A qualified health professional injects the solution using aseptic technique, selecting the appropriate dose and site based on the intended procedure.

The most serious risks involve systemic toxicity, which can manifest as central nervous system symptoms such as seizures or profound depression, and cardiovascular effects including arrhythmias, hypotension, or cardiac arrest. Immediate medical intervention is required if these signs appear.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, individuals with severe heart block, and those with significant hepatic impairment should avoid Lidosen unless the therapeutic benefit clearly outweighs the potential risks.